1. Home
  2. BMRN vs PAA Comparison

BMRN vs PAA Comparison

Compare BMRN & PAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMRN
  • PAA
  • Stock Information
  • Founded
  • BMRN 1996
  • PAA 1981
  • Country
  • BMRN United States
  • PAA United States
  • Employees
  • BMRN N/A
  • PAA N/A
  • Industry
  • BMRN Biotechnology: Pharmaceutical Preparations
  • PAA Natural Gas Distribution
  • Sector
  • BMRN Health Care
  • PAA Energy
  • Exchange
  • BMRN Nasdaq
  • PAA Nasdaq
  • Market Cap
  • BMRN 11.3B
  • PAA 12.1B
  • IPO Year
  • BMRN 1999
  • PAA N/A
  • Fundamental
  • Price
  • BMRN $57.54
  • PAA $17.52
  • Analyst Decision
  • BMRN Buy
  • PAA Hold
  • Analyst Count
  • BMRN 23
  • PAA 12
  • Target Price
  • BMRN $93.14
  • PAA $20.45
  • AVG Volume (30 Days)
  • BMRN 2.5M
  • PAA 3.0M
  • Earning Date
  • BMRN 08-04-2025
  • PAA 08-08-2025
  • Dividend Yield
  • BMRN N/A
  • PAA 8.68%
  • EPS Growth
  • BMRN 154.69
  • PAA N/A
  • EPS
  • BMRN 3.40
  • PAA 0.89
  • Revenue
  • BMRN $3,063,608,000.00
  • PAA $47,796,000,000.00
  • Revenue This Year
  • BMRN $12.34
  • PAA N/A
  • Revenue Next Year
  • BMRN $10.01
  • PAA $15.48
  • P/E Ratio
  • BMRN $16.93
  • PAA $26.68
  • Revenue Growth
  • BMRN 18.36
  • PAA N/A
  • 52 Week Low
  • BMRN $52.93
  • PAA $15.58
  • 52 Week High
  • BMRN $94.85
  • PAA $21.00
  • Technical
  • Relative Strength Index (RSI)
  • BMRN 47.03
  • PAA 35.03
  • Support Level
  • BMRN $56.45
  • PAA $17.51
  • Resistance Level
  • BMRN $58.62
  • PAA $17.91
  • Average True Range (ATR)
  • BMRN 1.95
  • PAA 0.38
  • MACD
  • BMRN -0.25
  • PAA -0.08
  • Stochastic Oscillator
  • BMRN 15.51
  • PAA 8.28

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.

About PAA Plains All American Pipeline L.P.

Plains All American Pipeline LP through its subsidiaries, engages in the pipeline transportation, terminaling, storage, and gathering of crude oil and natural gas liquids (NGL) in the United States and Canada. The company operates through two segments, Crude Oil and NGL. The Crude Oil segment offers gathering and transporting crude oil through pipelines, gathering systems, trucks, and barges or railcars. The NGL segment is involved in natural gas processing and NGL fractionation, storage, transportation, and terminalling. It generates the majority of its revenue from the Crude Oil segment.

Share on Social Networks: